131I Tositumomab

被引：0
|
作者：
Christine R. Culy
Harriet M. Lamb
机构：
[1] Adis International Limited,
来源：
BioDrugs | 2000年 / 14卷
关键词：
Fludarabine; Objective Response Rate; Autologous Stem Cell Transplant; Unlabelled Antibody; Tositumomab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
▴ 131I tositumomab is a radiolabelled murine anti-CD20 monoclonal antibody that binds specifically to the CD20 antigen on normal and malignant B lymphocytes. It has antitumour activity as a result of emission of beta particles, and activation of antibody-dependent cellular and complement-mediated cytotoxicity.
引用
收藏
页码：195 / 202
页数：7
相关论文
共 50 条
  • [21] URINARY EXCRETION OF 131I COMPOUNDS AFTER ADMINISTRATION OF 131I THYROXINE
    BLOMSTEDT, B
    ACTA ENDOCRINOLOGICA, 1965, 48 (03): : 481 - +
  • [22] Thymic uptake in 131I (131I) whole body scan.
    Yeung, HW
    Pandit-Taskar, N
    Simon, J
    Larson, SM
    JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (05) : 323P - 323P
  • [23] Efficient and Practical Radiosynthesis of Novel [131I]-Xanthine and [131I]-Hypoxanthine
    Wongso, H.
    Nuraeni, W.
    Rosyidiah, E.
    ATOM INDONESIA, 2022, 48 (03) : 185 - 191
  • [24] Study on removal of 131I from liquid waste in 131I production
    Liu, Yishu
    Han, Dongqiao
    Bao, Jianying
    Wang, Aimin
    Cheng, Zuoyong
    Chai, Dean
    Hedongli Gongcheng/Nuclear Power Engineering, 1998, 19 (05): : 476 - 480
  • [25] A practical methodology for patient release after tositumomab and 131I-tositumomab therapy
    Siegel, JA
    Kroll, S
    Regan, D
    Kaminski, MS
    Wahl, RL
    JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (03) : 354 - 363
  • [26] Iodine-131 Tositumomab131I-anti-B1 antibody, 131I-tositumomab, anti-CD20 murine monoclonal antibody-I-131, B1, Bexxar-, 131I-anti-B1 antibody, iodine-131 tositumomab, iodine-131 anti-B1 antibody, tositumomab
    BioDrugs, 2003, 17 (4) : 290 - 295
  • [27] 131I生产废液中131I的净化方法研究
    刘宜树
    韩冬桥
    包建英
    王爱民
    程作用
    柴德安
    核动力工程, 1998, (05) : 92 - 95
  • [28] Iodine-131 tositumomab -: 131I-anti-B1 antibody, 131I-tositumomab, anti-CD20 murine monoclonal antibody-I-131, B1, Bexxar™, 131I-anti-B1 antibody, iodine-131 tositumomab, iodine-131 anti-B1 antibody, tositumomab
    不详
    BIODRUGS, 2003, 17 (04) : 290 - 295
  • [29] Initial experience with tositumomab and iodine I 131 tositumomab for treatment of relapsed/refractory Hodgkin lymphoma
    Jacene, Heather
    Kasamon, Yvette
    Ambinder, Richard
    Serena, Donna
    Kasecamp, Wayne
    Wahl, Richard
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [30] Dosimetry in patients with B-cell lymphoma treated with [90Y]ibritumomab tiuxetan or [131I]tositumomab
    Sjogreen-Gleisner, K.
    Dewaraja, Y. K.
    Chiesa, C.
    Tennvall, J.
    Linden, O.
    Strand, S-E
    Ljungberg, M.
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 55 (02): : 126 - 154
12345